Legal Representation
Attorney
Kathleen A. Costigan
USPTO Deadlines
Next Deadline
143 days remaining
NOA E-Mailed - SOU Required
Due Date
May 16, 2026
Application History
35 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Nov 19, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 18, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Nov 16, 2025 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Nov 17, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 17, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 17, 2025 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| May 16, 2025 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| May 16, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 12, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 11, 2025 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Nov 18, 2024 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Feb 11, 2025 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Nov 18, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 17, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 16, 2024 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| May 16, 2024 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| May 16, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Nov 18, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 16, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Nov 16, 2023 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Nov 16, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 16, 2023 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Mar 21, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 21, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 1, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 15, 2023 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 18, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 17, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 17, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 14, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 14, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Jul 14, 2022 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jun 23, 2022 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 25, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 25, 2021 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Drug delivery agents in hypercompressed solid dosage form for implantation under the skin or within the tissue of a bodily organ or within a bodily structure, that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in hypercompressed solid dosage form for injection under the skin or within the tissue of a bodily organ or within a bodily structure, that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in hypercompressed solid dosage form for inhalation or taken orally or placed on the skin for local absorption through the skin, that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in a hypercompressed dosage form in a liquid for implantation under the skin or within the tissue of a bodily organ or within a bodily structure, that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in a hypercompressed dosage form in a liquid for injection under the skin or within the tissue of a bodily organ or within a bodily structure, that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in a hypercompressed dosage form in a liquid for inhalation or taken orally or placed on the skin for local absorption through the skin, that provide controlled release of the active ingredients for a wide variety of pharmaceuticals
Classification
International Classes
005